TickerStat.com

Nuo Therapeutics, Inc. (AURX)

Price—Loading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

13 annual periodsNewest to oldest
2025202420232022202120182017201520142013201220112010
Revenue$3.3M$1.4M$608,525$112,250$0$1.4M$721,045$11.5M$7.8M$11.6M$10.6M$7.2M$3.9M
Gross profit$2.2M$1.1M$482,433$93,036$0$1.2M−$369,997$3.5M$991,191$3.1M$6.6M$4.5M$2.3M
Research & development————$0$576,192$1.3M$2.6M$4.0M$3.8M$3.4M$98,148$415,633
Operating expenses$4.7M$3.5M$3.7M$3.4M$90,670$2.7M$15.2M$44.9M$24.4M$21.2M$19.5M$8.0M$7.7M
Operating income−$2.5M−$2.5M−$3.2M−$3.3M−$90,670−$1.5M−$15.5M−$41.3M−$23.4M−$18.1M−$12.9M−$3.5M−$5.4M
EBITDAderived————−$90,670−$1.4M−$14.4M−$40.6M−$22.8M−$17.0M−$11.7M−$2.9M−$5.0M
Net income−$2.5M−$2.3M−$3.2M−$3.2M−$90,670−$1.5M−$15.0M−$52.8M−$18.9M−$20.2M−$19.8M−$3.5M−$6.8M
Basic EPSper diluted share-$0.05-$0.05-$0.08-$0.08-$0.03-$0.07-$1.02-$0.42-$0.16-$0.20-$0.24-$0.08-$0.23
Diluted EPSper diluted share————-$0.03-$0.07-$1.02-$0.42-$0.16-$0.20-$0.24-$0.08-$0.23
Review source filings at SEC.gov ↗

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys2$293.7K disclosed value
Sells (SEC code S)1$300.0K disclosed value
3 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Nov 28, 2025Form 4JORDEN DAVID EMERSONCEO/CFOSellCommon Stock200.0K$1.50$300.0K1.95M
Jul 30, 2025Form 4SHEEDY CHARLES ETenPercentOwnerBuyCommon Stock133.3K$1.50$200.0K11.57M
Sep 18, 2024Form 4SHEEDY CHARLES ETenPercentOwnerBuyCommon Stock125.0K$0.75$93.8K11.44M
Review ownership filings at SEC.gov ↗